Used in pharmaceutical research as a key intermediate in the development of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports binding to ATP sites in kinases, making it valuable in designing selective inhibitors. Also explored in medicinal chemistry for optimizing drug candidates with improved metabolic stability and bioavailability. Shows potential in the synthesis of novel antimicrobial and antiviral agents due to the quinoxaline core’s biological activity.